Modern Approaches to The Treatment of Restless Legs Syndrome: The Role of Dopaminergic Drugs
National Journal of Neurology · 31.12.2025 · 40-45
DOI: 10.61788/njn.v2i28.06 ↗Kurz gefasst
Fachartikel in der Zeitschrift National Journal of Neurology, online erschienen am 31.12.2025. Verfasst von M.T. Ganizoda und 4 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the efficacy and tolerability of pramipexole in patients with idiopathic restless legs syndrome (RLS). Material and methods. A prospective open-label pilot study included 11 patients with idiopathic RLS (aged 49–65 years) treated at the National Medical Center of the Republic of Tajikistan “Shifobakhsh”. Pramipexole was administered with dose titration up to 1.0 mg (n=6); the control group (n=5) received placebo. Treatment duration was 4 weeks. Clinical outcomes were assessed using the (International Restless Legs Syndrome Rating Scale) (IRLS), RLS Ordinal Scale, Clinical Global Impression – Improvement (CGI-I) and Patient Global Impression of Change (PGIC).
Results
After 4 weeks, the pramipexole group showed a significant reduction in IRLS scores (28.3±4.2 to 9.5±3.1; >65% improvement) and significant improvement on the RLS Ordinal Scale (p
Zitieren
APA
Ganizoda, M., Tolibova, L., Isrofilzoda, M., Asilova, N., & Kurbonova, M. (2025). Modern Approaches to The Treatment of Restless Legs Syndrome: The Role of Dopaminergic Drugs. National Journal of Neurology, 40-45. https://doi.org/10.61788/njn.v2i28.06
Vancouver
Ganizoda M, Tolibova L, Isrofilzoda M, Asilova N, Kurbonova M. Modern Approaches to The Treatment of Restless Legs Syndrome: The Role of Dopaminergic Drugs. National Journal of Neurology. 2025:40-45. doi:10.61788/njn.v2i28.06
BibTeX
@article{Ganizoda2025,
author = {Ganizoda, M.T. and Tolibova, L.N. and Isrofilzoda, M.O. and Asilova, N.G. and Kurbonova, M.N.},
title = {Modern Approaches to The Treatment of Restless Legs Syndrome: The Role of Dopaminergic Drugs},
journal = {National Journal of Neurology},
year = {2025},
pages = {40--45},
doi = {10.61788/njn.v2i28.06}
}
EUVIMED